HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevalence and Natural History of Superficial Siderosis: A Population-Based Study.

AbstractBACKGROUND AND PURPOSE:
Superficial siderosis (SS) is characterized by hemosiderin deposition in the superficial layers of the central nervous system and can be seen during postmortem examination or with iron-sensitive magnetic resonance imaging techniques. The distribution of SS may predict the probable underlying cause. This study aimed to report the prevalence and natural history of SS in a population-based study.
METHODS:
Brain magnetic resonance imaging scans from the MCSA (Mayo Clinic Study of Aging), a population-based study of residents 50 to 89 years of age in Olmsted County, Minnesota, were reviewed. Participants with imaging consistent with SS were identified from 2011 through 2016. An inverse probability weighting approach was used to convert our observed frequencies to population prevalence of SS. Additional data abstracted included amyloid positron emission tomography, Apolipoprotein E genotype, coexisting cerebral microbleeds, and extent of SS.
RESULTS:
A total of 1412 participants had eligible magnetic resonance imaging scans. Two participants had infratentorial SS, restricted to the posterior fossa. Thirteen participants had cortical SS involving the cerebral convexities (7 focal and 6 disseminated). Only 3 of the participants with cortical SS (23%) also had cerebral microbleeds. The population prevalence of SS was 0.21% (95% confidence interval, 0-0.45) in those 50 to 69 years old and 1.43% (confidence interval, 0.53-2.34) in those over 69 years old. Apolipoprotein E ε2 allele was more common in those with SS (57.1% versus 15.0%; P<0.001). Compared with participants without SS, those with SS were also more likely to have a positive amyloid positron emission tomographic scan (76.9% versus 29.8%; P<0.001).
CONCLUSIONS:
SS may be encountered in the general elderly population. The association with increased amyloid burden and Apolipoprotein E ε2 genotype supports cerebral amyloid angiopathy as the most common mechanism. Longitudinal follow-up is needed to evaluate the risk of subsequent hemorrhage in cases of incidentally discovered SS.
AuthorsMichael Pichler, Prashanthi Vemuri, Alejandro A Rabinstein, Jeremiah Aakre, Kelly D Flemming, Robert D Brown Jr, Neeraj Kumar, Kejal Kantarci, Walter Kremers, Michelle M Mielke, David S Knopman, Clifford R Jack Jr, Ronald C Petersen, Val Lowe, Jonathan Graff-Radford
JournalStroke (Stroke) Vol. 48 Issue 12 Pg. 3210-3214 (12 2017) ISSN: 1524-4628 [Electronic] United States
PMID29070715 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2017 American Heart Association, Inc.
Chemical References
  • Amyloid
  • Apolipoprotein E2
Topics
  • Aged
  • Aged, 80 and over
  • Amyloid (genetics, metabolism)
  • Apolipoprotein E2 (genetics)
  • Cerebral Small Vessel Diseases (epidemiology, genetics)
  • Female
  • Genotype
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Minnesota (epidemiology)
  • Population
  • Positron-Emission Tomography
  • Prevalence
  • Risk Factors
  • Siderosis (diagnostic imaging, epidemiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: